286 related articles for article (PubMed ID: 21228139)
1. Baseline meningococcal carriage in Burkina Faso before the introduction of a meningococcal serogroup A conjugate vaccine.
Kristiansen PA; Diomandé F; Wei SC; Ouédraogo R; Sangaré L; Sanou I; Kandolo D; Kaboré P; Clark TA; Ouédraogo AS; Absatou KB; Ouédraogo CD; Hassan-King M; Thomas JD; Hatcher C; Djingarey M; Messonnier N; Préziosi MP; LaForce M; Caugant DA
Clin Vaccine Immunol; 2011 Mar; 18(3):435-43. PubMed ID: 21228139
[TBL] [Abstract][Full Text] [Related]
2. Persistent low carriage of serogroup A Neisseria meningitidis two years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac.
Kristiansen PA; Ba AK; Ouédraogo AS; Sanou I; Ouédraogo R; Sangaré L; Diomandé F; Kandolo D; Saga IM; Misegades L; Clark TA; Préziosi MP; Caugant DA
BMC Infect Dis; 2014 Dec; 14():663. PubMed ID: 25472422
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic and genotypic characterization of meningococcal carriage and disease isolates in Burkina Faso after mass vaccination with a serogroup a conjugate vaccine.
Kristiansen PA; Ba AK; Sanou I; Ouédraogo AS; Ouédraogo R; Sangaré L; Diomandé F; Kandolo D; Thomas JD; Clark TA; Laforce M; Caugant DA
BMC Infect Dis; 2013 Aug; 13():363. PubMed ID: 23914778
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and epidemiology of meningococcal carriage in Southern Ethiopia prior to implementation of MenAfriVac, a conjugate vaccine.
Bårnes GK; Kristiansen PA; Beyene D; Workalemahu B; Fissiha P; Merdekios B; Bohlin J; Préziosi MP; Aseffa A; Caugant DA
BMC Infect Dis; 2016 Nov; 16(1):639. PubMed ID: 27814682
[TBL] [Abstract][Full Text] [Related]
5. Molecular insights into meningococcal carriage isolates from Burkina Faso 7 years after introduction of a serogroup A meningococcal conjugate vaccine.
Topaz N; Kristiansen PA; Schmink S; Congo-Ouédraogo M; Kambiré D; Mbaeyi S; Paye M; Sanou M; Sangaré L; Ouédraogo R; Wang X
Microb Genom; 2020 Dec; 6(12):. PubMed ID: 33332261
[TBL] [Abstract][Full Text] [Related]
6. Meningococcal carriage 7 years after introduction of a serogroup A meningococcal conjugate vaccine in Burkina Faso: results from four cross-sectional carriage surveys.
Mbaeyi S; Sampo E; Dinanibè K; Yaméogo I; Congo-Ouédraogo M; Tamboura M; Sawadogo G; Ouattara K; Sanou M; Kiemtoré T; Dioma G; Sanon B; Somlaré H; Kyetega A; Ba AK; Aké F; Tarbangdo F; Aboua FA; Donnou Y; Kamaté I; Patel JC; Schmink S; Spiller MW; Topaz N; Novak R; Wang X; Bicaba B; Sangaré L; Ouédraogo-Traoré R; Kristiansen PA
Lancet Infect Dis; 2020 Dec; 20(12):1418-1425. PubMed ID: 32653071
[TBL] [Abstract][Full Text] [Related]
7. Evolution of meningococcal carriage in serogroups X and Y before introduction of MenAfriVac in the health district of Kaya, Burkina Faso.
Ba AK; Sanou I; Kristiansen PA; Sangaré L; Ouédraogo R; Ouattara K; Kienou M; Tiendrebeogo S; Tranchot J
BMC Infect Dis; 2014 Oct; 14():546. PubMed ID: 25311771
[TBL] [Abstract][Full Text] [Related]
8. Young-adult carriers of Neisseria meningitidis in Puglia (Italy): will the pattern of circulating meningococci change following the introduction of meningococcal serogroup C conjugate vaccines?
Germinario C; Tafuri S; Napoli C; Montagna MT; Balducci MT; Fortunato F; Martinelli D; Prato R
Hum Vaccin; 2010 Dec; 6(12):1025-7. PubMed ID: 21150271
[TBL] [Abstract][Full Text] [Related]
9. Limited Impact of Adolescent Meningococcal ACWY Vaccination on Neisseria meningitidis Serogroup W Carriage in University Students.
Oldfield NJ; Green LR; Parkhill J; Bayliss CD; Turner DPJ
J Infect Dis; 2018 Jan; 217(4):608-616. PubMed ID: 29155998
[TBL] [Abstract][Full Text] [Related]
10. Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity.
Kristiansen PA; Diomandé F; Ba AK; Sanou I; Ouédraogo AS; Ouédraogo R; Sangaré L; Kandolo D; Aké F; Saga IM; Clark TA; Misegades L; Martin SW; Thomas JD; Tiendrebeogo SR; Hassan-King M; Djingarey MH; Messonnier NE; Préziosi MP; Laforce FM; Caugant DA
Clin Infect Dis; 2013 Feb; 56(3):354-63. PubMed ID: 23087396
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of invasive meningococcal isolates from countries in the African meningitis belt before introduction of a serogroup A conjugate vaccine.
Caugant DA; Kristiansen PA; Wang X; Mayer LW; Taha MK; Ouédraogo R; Kandolo D; Bougoudogo F; Sow S; Bonte L
PLoS One; 2012; 7(9):e46019. PubMed ID: 23029368
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Oropharyngeal Carriage Isolates of Neisseria meningitidis in Healthy Korean Adolescents in 2015.
Kim HW; Lee S; Kwon D; Cha J; Ahn JG; Kim KH
J Korean Med Sci; 2017 Jul; 32(7):1111-1117. PubMed ID: 28581267
[TBL] [Abstract][Full Text] [Related]
13. Carriage of Neisseria lactamica in 1- to 29-year-old people in Burkina Faso: epidemiology and molecular characterization.
Kristiansen PA; Diomandé F; Ouédraogo R; Sanou I; Sangaré L; Ouédraogo AS; Ba AK; Kandolo D; Dolan Thomas J; Clark TA; Préziosi MP; Laforce FM; Caugant DA
J Clin Microbiol; 2012 Dec; 50(12):4020-7. PubMed ID: 23035186
[TBL] [Abstract][Full Text] [Related]
14. Molecular characteristics and epidemiology of meningococcal carriage, Burkina Faso, 2003.
Mueller JE; Sangaré L; Njanpop-Lafourcade BM; Tarnagda Z; Traoré Y; Yaro S; Borrow R; Gessner BD; Nicolas P
Emerg Infect Dis; 2007 Jun; 13(6):847-54. PubMed ID: 17553222
[TBL] [Abstract][Full Text] [Related]
15. Genotypic and phenotypic characterization of carriage and invasive disease isolates of Neisseria meningitidis in Finland.
Jounio U; Saukkoriipi A; Bratcher HB; Bloigu A; Juvonen R; Silvennoinen-Kassinen S; Peitso A; Harju T; Vainio O; Kuusi M; Maiden MC; Leinonen M; Käyhty H; Toropainen M
J Clin Microbiol; 2012 Feb; 50(2):264-73. PubMed ID: 22135261
[TBL] [Abstract][Full Text] [Related]
16. Meningococcal carriage among a university student population - United States, 2015.
Breakwell L; Whaley M; Khan UI; Bandy U; Alexander-Scott N; Dupont L; Vanner C; Chang HY; Vuong JT; Martin S; MacNeil JR; Wang X; Meyer SA
Vaccine; 2018 Jan; 36(1):29-35. PubMed ID: 29183735
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of invasive meningococcal isolates in Burkina Faso as the relative importance of serogroups X and W increases, 2008-2012.
Retchless AC; Congo-Ouédraogo M; Kambiré D; Vuong J; Chen A; Hu F; Ba AK; Ouédraogo AS; Hema-Ouangraoua S; Patel JC; Traoré RO; Sangaré L; Wang X
BMC Infect Dis; 2018 Jul; 18(1):337. PubMed ID: 30021533
[TBL] [Abstract][Full Text] [Related]
18. Carriage rates and risk factors during an outbreak of invasive meningococcal disease due to Neisseria meningitidis serogroup C ST-11 (cc11) in Tuscany, Italy: a cross-sectional study.
Miglietta A; Innocenti F; Pezzotti P; Riccobono E; Moriondo M; Pecile P; Nieddu F; Rossolini GM; Azzari C; ; Balocchini E; Rezza G; Voller F; Stefanelli P
BMC Infect Dis; 2019 Jan; 19(1):29. PubMed ID: 30621624
[TBL] [Abstract][Full Text] [Related]
19. Carriage meningococcal isolates with capsule null locus dominate among high school students in a non-endemic period, Italy, 2012-2013.
Neri A; Fazio C; Ambrosio L; Vacca P; Barbui A; Daprai L; Vocale C; Santino I; Conte M; Rossi L; Ciammaruconi A; Anselmo A; Lista F; Stefanelli P
Int J Med Microbiol; 2019; 309(3-4):182-188. PubMed ID: 30878541
[TBL] [Abstract][Full Text] [Related]
20. Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity.
Maiden MC; Ibarz-Pavón AB; Urwin R; Gray SJ; Andrews NJ; Clarke SC; Walker AM; Evans MR; Kroll JS; Neal KR; Ala'aldeen DA; Crook DW; Cann K; Harrison S; Cunningham R; Baxter D; Kaczmarski E; Maclennan J; Cameron JC; Stuart JM
J Infect Dis; 2008 Mar; 197(5):737-43. PubMed ID: 18271745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
